Fingerprint
Dive into the research topics of 'ARQ 092, an orally-available, selective AKT inhibitor, attenuates neutrophil-platelet interactions in sickle cell disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
ARQ 092, an orally-available, selective AKT inhibitor, attenuates neutrophil-platelet interactions in sickle cell disease
Kyungho Kim, Jing Li, Andrew Barazia, Alan Tseng, Seock Won Youn, Giovanni Abbadessa, Yi Yu, Brian Schwartz, Robert K. Andrews, Victor R. Gordeuk, Jaehyung Cho
Research output: Contribution to journal › Article › peer-review
24
Scopus
citations